Stefanie Aust

2.5k total citations · 1 hit paper
59 papers, 1.9k citations indexed

About

Stefanie Aust is a scholar working on Reproductive Medicine, Oncology and Cancer Research. According to data from OpenAlex, Stefanie Aust has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Reproductive Medicine, 18 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Stefanie Aust's work include Ovarian cancer diagnosis and treatment (32 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Intraperitoneal and Appendiceal Malignancies (6 papers). Stefanie Aust is often cited by papers focused on Ovarian cancer diagnosis and treatment (32 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Intraperitoneal and Appendiceal Malignancies (6 papers). Stefanie Aust collaborates with scholars based in Austria, Germany and Belgium. Stefanie Aust's co-authors include Dietmar Pils, Anna Bachmayr-Heyda, Katharina Auer, Robert Zeillinger, Nyamdelger Sukhbaatar, Agnes T. Reiner, Christoph Grimm, Thomas W. Grunt, Ildikó Mesteri and Stephan Polterauer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Stefanie Aust

55 papers receiving 1.9k citations

Hit Papers

Correlation of circular RNA abundance with proliferation ... 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Aust Austria 21 960 832 436 367 243 59 1.9k
Rebecca A. Previs United States 21 496 0.5× 286 0.3× 469 1.1× 330 0.9× 150 0.6× 122 1.5k
Xingsheng Yang China 27 800 0.8× 412 0.5× 409 0.9× 334 0.9× 169 0.7× 95 1.8k
Kyosuke Yamada Japan 16 589 0.6× 218 0.3× 355 0.8× 283 0.8× 240 1.0× 52 1.6k
Laura Zanotti Italy 27 546 0.6× 352 0.4× 527 1.2× 732 2.0× 150 0.6× 76 1.9k
Yuan Cheng China 18 513 0.5× 291 0.3× 298 0.7× 101 0.3× 133 0.5× 100 1.3k
Kai Zhou China 20 590 0.6× 378 0.5× 263 0.6× 78 0.2× 112 0.5× 74 1.2k
Sophia Apostolidou United Kingdom 18 1.0k 1.1× 320 0.4× 291 0.7× 117 0.3× 60 0.2× 42 1.5k
Xiaoling Liu China 17 845 0.9× 282 0.3× 955 2.2× 68 0.2× 135 0.6× 57 2.0k
J Kulpa Poland 17 329 0.3× 218 0.3× 352 0.8× 314 0.9× 72 0.3× 51 1.2k
Mauricio P. Pinto Chile 20 462 0.5× 298 0.4× 438 1.0× 66 0.2× 109 0.4× 56 1.4k

Countries citing papers authored by Stefanie Aust

Since Specialization
Citations

This map shows the geographic impact of Stefanie Aust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Aust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Aust more than expected).

Fields of papers citing papers by Stefanie Aust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Aust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Aust. The network helps show where Stefanie Aust may publish in the future.

Co-authorship network of co-authors of Stefanie Aust

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Aust. A scholar is included among the top collaborators of Stefanie Aust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Aust. Stefanie Aust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pils, Dietmar, Stefanie Aust, Christoph Grimm, et al.. (2022). Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients. Journal of Personalized Medicine. 12(9). 1467–1467.
3.
Watrowski, Rafał, Eva Obermayr, Christine Wallisch, et al.. (2022). Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study. Cancers. 14(7). 1780–1780. 10 indexed citations
4.
Hofstetter, Gerda, Dietmar Pils, Johannes Pammer, et al.. (2022). Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer. Journal of Personalized Medicine. 12(4). 551–551. 9 indexed citations
5.
Reiser, Elisabeth, Dietmar Pils, Christoph Grimm, et al.. (2022). Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters. Cancers. 14(13). 3210–3210. 1 indexed citations
6.
Obermayr, Eva, Elena Ioana Braicu, Stephan Polterauer, et al.. (2021). Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium. Cancers. 13(23). 5865–5865. 4 indexed citations
7.
Oberndorfer, Felicitas, Christoph Grimm, Stephan Polterauer, et al.. (2021). Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data. Journal of Personalized Medicine. 11(1). 48–48. 14 indexed citations
8.
Bekos, Christine, et al.. (2020). The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer. Journal of Gynecologic Oncology. 32(1). e1–e1. 19 indexed citations
9.
Aust, Stefanie, et al.. (2020). Screening for ovarian cancer: is there still hope?. memo - Magazine of European Medical Oncology. 13(2). 189–192. 6 indexed citations
10.
Taghizadeh, Hossein, Matthias Unseld, Robert M. Mader, et al.. (2020). Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI. Journal of Personalized Medicine. 10(4). 188–188. 7 indexed citations
11.
Aust, Stefanie, Richard Schwameis, Leonhard Müllauer, et al.. (2020). Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer. Cancers. 12(3). 548–548. 15 indexed citations
12.
Kasimir‐Bauer, Sabine, Joanna Roder, Eva Obermayr, et al.. (2020). Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer. Cancers. 12(9). 2519–2519. 2 indexed citations
13.
Bekos, Christine, Besnik Muqaku, Sabine Dekan, et al.. (2019). NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach. Cancers. 11(5). 698–698. 30 indexed citations
14.
Seebacher, Veronika, Alina Sturdza, Stephan Polterauer, et al.. (2018). Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score. Archives of Gynecology and Obstetrics. 299(4). 1055–1062. 13 indexed citations
15.
Bachmayr-Heyda, Anna, Stefanie Aust, Katharina Auer, et al.. (2016). Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 23(8). 2081–2092. 54 indexed citations
16.
Bachmayr-Heyda, Anna, Stefanie Aust, Georg Heinze, et al.. (2013). Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium. BMC Cancer. 13(1). 422–422. 54 indexed citations
17.
Aust, Stefanie, Anna Bachmayr-Heyda, Dietmar Pils, et al.. (2013). Determination of Tumor-infiltrating CD8+ Lymphocytes in Human Ovarian Cancer. International Journal of Gynecological Pathology. 32(3). 269–276. 10 indexed citations
18.
Aust, Stefanie, Anna Bachmayr-Heyda, Petra Pateisky, et al.. (2012). Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium. Molecular Cancer. 11(1). 69–69. 36 indexed citations
19.
Pils, Dietmar, Gudrun Hager, Dan Cacsire Castillo‐Tong, et al.. (2012). Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of theOVCADConsortium. Cancer Science. 103(7). 1334–1341. 51 indexed citations
20.
Ott, Johannes, Stefanie Aust, Regina Promberger, Johannes C. Huber, & Ulrike Kaufmann. (2011). Cross-Sex Hormone Therapy Alters the Serum Lipid Profile: A Retrospective Cohort Study in 169 Transsexuals. The Journal of Sexual Medicine. 8(8). 2361–2369. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026